FR2370476A2 - Procede d'extraction d'un compose hyperglycemiant - Google Patents

Procede d'extraction d'un compose hyperglycemiant

Info

Publication number
FR2370476A2
FR2370476A2 FR7633847A FR7633847A FR2370476A2 FR 2370476 A2 FR2370476 A2 FR 2370476A2 FR 7633847 A FR7633847 A FR 7633847A FR 7633847 A FR7633847 A FR 7633847A FR 2370476 A2 FR2370476 A2 FR 2370476A2
Authority
FR
France
Prior art keywords
factor
hyperglycaemic
bone marrow
elimination
red bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR7633847A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7633847A priority Critical patent/FR2370476A2/fr
Priority to US05/742,908 priority patent/US4136170A/en
Priority to SE7612983A priority patent/SE7612983L/xx
Priority to DE19762652726 priority patent/DE2652726A1/de
Priority to DK523876A priority patent/DK523876A/da
Priority to IT29520/76A priority patent/IT1067564B/it
Priority to AU19791/76A priority patent/AU1979176A/en
Priority to ES453470A priority patent/ES453470A1/es
Priority to LU76235A priority patent/LU76235A1/xx
Priority to JP13964176A priority patent/JPS5315405A/ja
Priority to GB48593/76A priority patent/GB1528087A/en
Priority to NL7613009A priority patent/NL7613009A/xx
Publication of FR2370476A2 publication Critical patent/FR2370476A2/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Procédé d'extraction d'un facteur hyperglycémiant à partir de moelle osseuse rouge contenue dans les os plats. Ce procédé consiste, après séparation des parties dures, à effectuer l'extraction du produit actif sur la poudre acétonique obtenue après l'élimination des substances acétosolubles, extraction exécutée dans les conditions du brevet principal, ainsi que selon des perfectionnements, tels que : extraction par tampon salin, par des solutions hydroalcooliques, par cryoprécipitation.
FR7633847A 1975-11-21 1976-11-10 Procede d'extraction d'un compose hyperglycemiant Pending FR2370476A2 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR7633847A FR2370476A2 (fr) 1976-11-10 1976-11-10 Procede d'extraction d'un compose hyperglycemiant
US05/742,908 US4136170A (en) 1975-11-21 1976-11-18 Method of extracting a hyperglycemic factor
SE7612983A SE7612983L (sv) 1975-11-21 1976-11-19 Forfarande for framstellning av en hyperglykemifaktor
DE19762652726 DE2652726A1 (de) 1975-11-21 1976-11-19 Blutzuckeranhebende substanz, extraktionsverfahren zur gewinnung derselben und diese enthaltende pharmazeutische mittel
DK523876A DK523876A (da) 1975-11-21 1976-11-19 Fremgangsmade til extraktion af en hyperglycemisk virkende forbindelse
IT29520/76A IT1067564B (it) 1975-11-21 1976-11-19 Procedimento di estrauione di un compostio iperglicemizzante
AU19791/76A AU1979176A (en) 1975-11-21 1976-11-19 Method of extracting a hyperglycemic factor
ES453470A ES453470A1 (es) 1975-11-21 1976-11-19 Procedimiento de preparacion de un factor hiperglicemiante.
LU76235A LU76235A1 (fr) 1975-11-21 1976-11-19
JP13964176A JPS5315405A (en) 1975-11-21 1976-11-22 Extraction of high blood sugar factor
GB48593/76A GB1528087A (en) 1975-11-21 1976-11-22 Method of extracting a hyperglycemic factor
NL7613009A NL7613009A (nl) 1975-11-21 1976-11-22 Werkwijze voor het extraheren van een hyper- glycemeriserende verbinding.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7633847A FR2370476A2 (fr) 1976-11-10 1976-11-10 Procede d'extraction d'un compose hyperglycemiant

Publications (1)

Publication Number Publication Date
FR2370476A2 true FR2370476A2 (fr) 1978-06-09

Family

ID=9179740

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7633847A Pending FR2370476A2 (fr) 1975-11-21 1976-11-10 Procede d'extraction d'un compose hyperglycemiant

Country Status (1)

Country Link
FR (1) FR2370476A2 (fr)

Similar Documents

Publication Publication Date Title
BG96316A (bg) Метод за изолиране на фактор viii
ENGH et al. Epidemiology of osteoporosis: II. incidence of hip fractures in mental institutions
DE3565935D1 (en) Composition for accelerating recovery of function of hematopoietic organs and the use thereof
FR2370476A2 (fr) Procede d'extraction d'un compose hyperglycemiant
FR2332025A1 (fr) Procede d'extraction d'un compose hyperglycemiant
FR2332024A2 (fr) Procede d'extraction et de separation d'une fraction hyperglycemiante de la moelle osseuse rouge
Shukla Plasma and urinary ascorbic acid levels in the postoperative period
Langford et al. Diuretic effect of angiotensin in the chicken.
GB1384332A (en) Flavouring agent
Carroll et al. A bipedal lizardlike reptile from the Karroo
Jacobson A case of multiple myelomata with chronic nephritis showing Bence-Jones protein in urine and blood serum
GB1140005A (en) A process for recovering nutritional elements from organic material
JPS5611762A (en) Production of protein jelly and its use
Gershon-Cohen et al. Fluorine in tea and caries in rats
HAYAMI Body Sway during One Foot Standing
Stehli A late Triassic terebratellacean from Peru
JPS5610115A (en) Preparation of placenta or umbilical cord extract
Hudson et al. The preparation and some metabolic properties of rat spinal cord slices
Kameyama et al. Pharmacological action of eptazocine (1lethy1-10-hydroxy-2 (1lethy1-10-hydroxy-2, 7-hexahydro-1 benzazonine)
MIRRAKHIMOVA The cardiovascular system in extreme natural conditions(Russian book)
SU111199A1 (ru) Способ экстрагировани из печени рогатого скота антианемического фактора (витамина В12)
Lowe Effects of isolation and conflict on voluntary alcohol consumption in rats.
Rahman The amino acid spectra of fish protein concentrates as a function of processing
Knyazev et al. Changes in the population of small-sized mammals of the range Tsagan-Bogdo(trans-Altai Gobi) in Late Holocene.
GEU1998330Y (en) Method for Treatment of Pyelonephrits